Gene therapy for vascular disease

Annals of Vascular Surgery
L B Schwartz, J Moawad

Abstract

Atherosclerosis is a degenerative process characterized by endothelial cell dysfunction, inflammatory cell adhesion and infiltration, and the accumulation of cellular and matrix elements leading to the formation of fibrocellular plaques. In the end stages, advanced occlusive plaques limit blood flow and oxygen delivery resulting in the well-known ischemic syndromes of the coronary, skeletal muscle, mesenteric, and cerebrovascular circulation. Moreover, sudden critical ischemic events may be precipitated by plaque disturbance, rupture, hemorrhage, and/or thrombosis. Traditional pharmacologic approaches have been effective in reducing serum cholesterol and controlling thrombosis but, in the main, have had little impact on the treatment of advanced lesions. The purpose of this review is to examine the current status of gene therapy for vascular proliferation, aberrant endothelial function, thrombosis, peripheral ischemia, and modification of the blood/biomaterial interface.

Citations

Dec 10, 1999·The Annals of Thoracic Surgery·D K DasD W Deaton

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

The American Journal of Cardiology
D P FaxonC C Haudenschild
Cardiologia : bollettino della Società italiana di cardiologia
A MarzocchiB Magnani
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
Massimo MontisciCristina Basso
Developments in Ophthalmology
Arnd Gandorfer
© 2021 Meta ULC. All rights reserved